CCB PRINCIPAL ASSECCB PRINCIPAL ASSECCB PRINCIPAL ASSE

CCB PRINCIPAL ASSE

No trades
See on Supercharts

About CCB PRINCIPAL ASSE

Issuer
CCB Principal Asset Management Co., Ltd.
Brand
CCB
Expense ratio
0.60%
Home page
Inception date
Mar 11, 2021
Index tracked
CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross
Management style
Passive
ISIN
CNE100004GD8
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err. Under normal market conditions, the absolute value of the Fund's daily average tracking deviation should not exceed 0.2%, and the annual tracking err should not exceed 2%.

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of December 31, 2023
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks97.68%
Health Technology88.69%
Commercial Services8.20%
Process Industries0.49%
Health Services0.30%
Bonds, Cash & Other2.32%
Cash2.32%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows